Caris Life Sciences (CAI) Financial Statements & Analysis

Caris Life Sciences (CAI) Income Statement

Caris Life Sciences reported revenue of $812.03M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 97.0% from $412.26M a year earlier. Caris Life Sciences posted a net loss of $537.96M, compared with a net loss of $378.26M a year earlier. Gross margin was 66.4% and operating margin 5.6%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $263.71M, up 45.4% from the same quarter a year earlier.

Caris Life Sciences Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Caris Life Sciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	812.03	412.26	306.13	258.49	294.01	416.54	432.10	348.39
Cost of Revenue	272.87	231.83	216.82	178.46	109.86	216.03	218.47	179.11
Gross Profit	539.17	178.78	89.31	80.02	184.16	200.51	213.63	169.29
Operating Expenses
Research & Development	45.31	111.50	116.88	101.27	0.00	0.00	0.00	0.00
Selling, General & Administrative	392.47	326.05	291.48	294.51	27.31	52.70	50.31	42.70
Operating Expenses	494.06	435.90	408.86	395.78	45.07	70.23	64.85	63.62
Operating Income	45.11	-257.12	-319.55	-315.76	139.09	130.28	148.78	105.67
Other Income/Expense
Interest Income	16.50	7.12	11.26	0.95	0.00	0.00	0.00	0.00
Interest Expense	56.85	-50.03	31.61	26.68	61.57	79.16	78.35	53.05
Other Income/Expense	-113.20	-24.77	-21.86	20.66	-109.55	0.00	-67.30	-48.47
Income
Income Before Tax	-68.09	-281.89	-341.42	-320.83	29.53	55.21	81.48	57.20
Income Tax Expense	469.87	0.00	0.00	0.00	1.80	4.19	2.89	-14.86
Net Income	-537.96	-378.26	-341.42	-320.83	27.73	31.01	78.60	72.06
Net Income - Continuous Operations	-537.96	-281.89	-341.42	-320.83	27.73	31.01	78.60	72.06
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-
EBITDA	11.38	-208.21	-260.80	-245.89	254.46	248.30	283.31	223.51
EBIT	-11.24	-257.12	-319.55	-294.15	-	-	-	-
Depreciation & Amortization	22.62	48.91	49.00	48.25	110.65	113.93	123.48	113.26
Earnings Per Share
Basic EPS	-2.00	-11.00	-2.00	-2.00	2.00	2.00	4.00	4.00
Diluted EPS	-2.00	-11.00	-2.00	-2.00	2.00	2.00	4.00	4.00
Basic Shares Outstanding	282.33	35.50	254.66	254.79	17.95	18.01	19.82	19.25
Diluted Shares Outstanding	289.89	35.50	254.66	254.79	17.95	18.01	19.82	19.61

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Caris Life Sciences Financial Statements

What was Caris Life Sciences's revenue in fiscal 2025?

Caris Life Sciences reported revenue of $812.03M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 97.0% from $412.26M a year earlier.

Is Caris Life Sciences profitable?

No. Caris Life Sciences reported a net loss of $537.96M in fiscal 2025. In fiscal 2024 it lost $378.26M.

What is Caris Life Sciences's operating margin?

Caris Life Sciences's operating income was $45.11M on revenue of $812.03M in fiscal 2025, an operating margin of 5.6%, compared with -62.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition